Results 111 to 120 of about 118,119 (154)

Impact of <i>TSC2</i> loss on progression-free survival in uterine carcinosarcoma: A retrospective analysis. [PDF]

Fujita Med J
Ichikawa R, Sudo T, Takada K, Ohwaki A, Ito M, Shimizu Y, Takeda M, Sugihara E, Takimoto T, Nishizawa H.   +9 more
europepmc   +1 more source

Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma. [PDF]

Gynecol Oncol Rep
Cham S, Xiong N, Tayob N, Krasner C, Wright AA, Lee EK, Sawyer H, Mathews C, Konstantinopoulos PA, Matulonis UA, Liu JF.   +10 more
europepmc   +1 more source

Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma. [PDF]

Int J Gynecol Cancer
Toboni M, Kurnit K, Erickson B, Powell M, Secord AA, Fader AN.   +5 more
europepmc   +1 more source

Real-world insights into the prevalence and prognostic significance of trophoblast cell-surface antigen 2 and folate receptor alpha in uterine carcinosarcoma. [PDF]

BMC Cancer
de Albuquerque LZ, da Silva JL, Rodrigues FR, Fernandes PV, Small IÁ, Leite LF, Guitmann G, de Melo AC.   +7 more
europepmc   +1 more source

Establishment and comparison of three sublines from a human uterine carcinosarcoma cell line, ESCA. [PDF]

Hum Cell
Long Y, Pei X, Liu H, Ouyang X, Jiang W, Yang H.   +5 more
europepmc   +1 more source

Overall survival after progression in patients with uterine carcinosarcoma: a single-center retrospective cohort study. [PDF]

Obstet Gynecol Sci
Buhachat R, Wangrangsimakul K, Thiangphak E, Jiamset I.   +3 more
europepmc   +1 more source

RETRACTION: Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma. [PDF]

Dis Markers
Markers D.
europepmc   +1 more source

GTSF1 promotes stemness in uterine carcinosarcoma through CCL1-mediated M1 macrophage aggregation. [PDF]

Am J Cancer Res
Li Y, Lan T, Liu M, Li C, Du Y.
europepmc   +1 more source

Quality of life and survival in patients with uterine carcinosarcoma: A tertiary center observational study. [PDF]

Gynecol Oncol Rep
Pham ENB, van den Berg CB, Boere I, de Geus V, Haagsma JA, Maliepaard M, Mens JWM, Groenendijk FH, van Beekhuizen HJ.   +8 more
europepmc   +1 more source

Molecular subtypes and quantitative analysis of PD-L1 and tumor-associated immune cells in uterine carcinosarcoma. [PDF]

J Gynecol Oncol
Sun L, Gao X, Zhao Z, Zhu Y.
europepmc   +1 more source